Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Clinical trial NCT06616597 · RECRUITING
Trial details
- NCT number
- NCT06616597
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2031-03-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.